TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012
TCL Archive NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive March 23, 1984
TCL Archive Anti-Impoundment, Panel Stay In Cancer Renewal Act; Conferees Finally Agree On Research Training Bill June 14, 1974
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
